Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $2.4B |
| Sales growthchange from the year before | +7.5% |
| Gross marginshare of sales left after the direct cost of what it sells | 61.0% |
| Operating marginshare of sales left after running the business | 21.5% |
| Net marginshare of sales kept as profit | 15.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | 18.1% |
| Return on invested capitalprofit made on each $100 put into the business | 18.1% |
| Return on equityprofit vs. shareholders' accounting value | 30.6% |
| Debt / equitydebt vs. shareholders' accounting value | 0.88 |
| Change in share countnegative = the company is buying back its shares | -2.1% |
2 insiders sold $4.5M (96% under pre-arranged plans) on the open market.
| Mansueto Joseph DExecutive Chairman · Director · 10% owner | Sold (plan)Aug 5 | 7,250 shat $201.06 · $1.5M |
| Mansueto Joseph DExecutive Chairman · Director · 10% owner | Sold (plan)Aug 4 | 7,250 shat $199.67 · $1.4M |
| Mansueto Joseph DExecutive Chairman · Director · 10% owner | Sold (plan)Aug 3 | 7,250 shat $199.20 · $1.4M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy